You have full text access to this OnlineOpen article

mTOR/p70S6k signalling alteration by Aβ exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease

  1. Claire Lafay-Chebassier1,4,†,
  2. Marc Paccalin2,4,†,
  3. Guylène Page4,
  4. Stéphanie Barc-Pain4,
  5. Marie Christine Perault-Pochat1,4,
  6. Roger Gil3,4,
  7. Laurent Pradier5,
  8. Jacques Hugon3,4

Article first published online: 10 JUN 2005

DOI: 10.1111/j.1471-4159.2005.03187.x

Issue

Journal of Neurochemistry

Journal of Neurochemistry

Volume 94, Issue 1, pages 215–225, July 2005

Additional Information

How to Cite

Lafay-Chebassier, C., Paccalin, M., Page, G., Barc-Pain, S., Perault-Pochat, M. C., Gil, R., Pradier, L. and Hugon, J. (2005), mTOR/p70S6k signalling alteration by Aβ exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. Journal of Neurochemistry, 94: 215–225. doi: 10.1111/j.1471-4159.2005.03187.x

Author Information

  1. 1

    Departments of Pharmacology

  2. 2

    Geriatrics

  3. 3

    Neurology, Poitiers University Hospital, Poitiers, France

  4. 4

    Research Group on Brain Aging (Equipe associée 3808), University of Poitiers, Poitiers, France

  5. 5

    Sanofi-Aventis, CRVA Vitry-sur-Seine, France

  1. †

    Claire Lafay-Chebassier and Marc Paccalin contributed equally to this work.

*Address correspondence and reprint requests to Jacques Hugon, Department of Neurology, CHU Poitiers, rue de la Miletrie, 86000 Poitiers, France. E-mail: jacques.hugon@univ-poitiers.fr

  • †

    Claire Lafay-Chebassier and Marc Paccalin contributed equally to this work.

Publication History

  1. Issue published online: 10 JUN 2005
  2. Article first published online: 10 JUN 2005
  3. Received January 12, 2005; revised manuscript received February 7, 2005; accepted February 23, 2005.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (375K)

References

  • Adunsky A., Baram D., Hershkowitz M. and Mekori Y. A. (1991) Increased cytosolic free calcium in lymphocytes of Alzheimer patients. J. Neuroimmunol. 33, 167–172.DOI: 10.1016/0165-5728(91)90060-K
  • Alirezaei M., Nairn A. C., Glowinski J., Premont J. and Marin P. (1999) Zinc inhibits protein synthesis in neurons. Potential role of phosphorylation of translation initiation factor-2alpha. J. Biol. Chem. 274, 32433–32438.DOI: 10.1074/jbc.274.45.32433
  • An W. L., Cowburn R. F., Li L., Braak H., Alafuzoff I., Iqbal K., Iqbal I. G., Winblad B. and Pei J. J. (2003) Up-regulation of phosphorylated/activated p70, S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease. Am. J. Pathol. 163, 591–607.
  • Baki L., Shioi J., Wen P., Shao Z., Schwarzman A., Gama-Sosa M., Neve R. and Robakis N. K. (2004) PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. EMBO J. 23, 2586–2596.
  • Bjornsti M. A. and Houghton P. J. (2004) The TOR pathway: a target for cancer therapy. Nat. Rev. Cancer 4, 335–348.
  • Blanchard V., Moussaoui S., Czech C. et al. (2003) Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice. Exp. Neurol. 184, 247–263.
  • Bolster D. R., Crozier S. J. and Jefferson L. S. (2002) AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J. Biol. Chem. 277, 23977–23980.
  • Cammalleri M., Lutjens R., Berton F., King A. R., Simpson C., Francesconi W. and Sanna P. P. (2003) Time-restricted role for dendritic activation of the mTOR-p70S6k pathway in the induction of late-phase long-term potentiation in the CA1. Proc. Natl Acad. Sci. USA 100, 14 368–14 373.
  • Castedo M., Ferri K. F. and Kroemer G. (2002) Mammalian target of rapamycin (mTOR): pro- and anti-apoptotic. Cell Death Differ. 2, 99–100.
  • Chang R. C., Wong A. K., Ng H. K. and Hugon J. (2002a) Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport 13, 2429–2432.
  • Chang R. C. C., Suen K. C., Ma C. H., Elyaman W., Ng H. K. and Hugon J. (2002b) Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J. Neurochem. 83, 1215–1225.
    Direct Link:
  • Clemens M. J. (2001) Translation regulation in cell stress and apoptosis. Roles of the eIF4E binding proteins. J. Cell. Mol. Med. 5, 221–239.
    Direct Link:
  • Culvenor J. G., Maher F., Evin G. et al. (1997) Alzheimer's disease-associated presenilin 1 in neuronal cells: evidence for localization to the endoplasmic reticulum-Golgi intermediate compartment. J. Neurosci. Res. 49, 719–731.
    Direct Link:
  • DeGracia D. J. , Adamczyk S., Folbe A. J. et al. (1999) Eukaryotic initiation factor 2alpha kinase and phosphatase activity during postischemic brain reperfusion. Exp. Neurol. 155, 221–227.
  • Dennis P. B., Pullen N., Pearson R. B., Kozma S. C. and Thomas G. (1998) Phosphorylation sites in the auto-inhibitory domain participate in p70 (s6k) activation loop phosphorylation. J. Biol. Chem. 273, 14 845–14 852.
  • Drenan R. M., Liu X., Bertram P. G. and Zheng X. F. (2004) FKBP12-rapamycin-associated protein or mammalian target of rapamycin (FRAP/mTOR) localization in the endoplasmic reticulum and the Golgi apparatus. J. Biol. Chem. 279, 772–778.
  • Dufner A. and Thomas G. (1999) Ribosomal S6 kinase signaling and the control of translation. Exp. Cell Res. 253, 100–109.
  • Eckert A., Forstl H., Zerfass R., Hennerici M. and Muller W. E. (1997) Free intracellular calcium in peripheral cells in Alzheimer's disease. Neurobiol. Aging 18, 281–284.
  • Eckert A., Oster M., Zerfass R., Hennerici M. and Muller W. E. (2001) Elevated levels of fragmented DNA nucleosomes in native and activated lymphocytes indicate an enhanced sensitivity to apoptosis in sporadic Alzheimer's disease. Specific differences to vascular dementia. Dement. Geriatr. Cogn. Disord. 12, 98–105.
  • Ferrer I. (2002) Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease. Neuropathol. Appl. Neurobiol. 28, 441–451.
    Direct Link:
  • Frerichs K. U., Smith C. B., Brenner M., DeGracia D. J., Krause G. S., Marrone L., Dever T. E. and Hallenbeck J. M. (1998) Suppression of protein synthesis in brain during hibernation involves inhibition of protein initiation and elongation. Proc. Natl Acad. Sci. USA 95, 14511–14516.
  • Gao X., Zhang Y., Arrazola P., Hino O., Kobayashi T., Yeung R. S., Ru B. and Pan D. (2002) Tsc tumour suppressor proteins antagonize amino-acid-TOR signaling. Nat. Cell Biol. 4, 699–704.
  • Gibson G. E., Nielsen P., Sherman K. A. and Blass J. P. (1987) Diminished mitogen-induced calcium uptake by lymphocytes from Alzheimer patients. Biol. Psychiatr. 22, 1079–1086.
  • Hannan K. M., Thomas G. and Pearson R. B. (2003) Activation of S6K1 (p70 ribosomal protein S6 kinase 1) requires an initial calcium-dependent priming event involving formation of a high-molecular-mass signalling complex. Biochem. J. 370, 469–477.
  • Harding H. P., Zhang Y. and Ron D. (1999) Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397, 271–274.
  • Inoki K., Zhu T. and Guan K. L. (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577–590.
  • Jeffrey I. W., Bushell M., Tilleray V. J., Morley S. and Clemens M. J. (2002) Inhibition of protein synthesis in apoptosis: differential requirements by the tumor necrosis factor alpha family and a DNA-damaging agent for caspases and the double-stranded RNA-dependent protein kinase. Cancer Res. 62, 2272–2280.
  • Joachim C. L., Morris J. H. and Selkoe D. J. (1989) Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. Am. J. Pathol. 135, 309–319.
  • Johnson G., Gotlib J., Haroutunian V., Bierer L., Nairn A. C., Merril C. and Wallace W. (1992) Increased phosphorylation of elongation factor 2 in Alzheimer's disease. Brain Res. Mol. Brain Res. 15, 319–326.
  • Kimball S. R., Vary T. C. and Jefferson L. S. (1992) Age-dependent decrease in the amount of eukaryotic initiation factor 2 in various rat tissues. Biochem. J. 286, 263–268.
  • Ladiges W., Morton J., Blakely C. and Gale M. (2000) Tissue specific expression of PKR protein kinase in aging B6D2F1 mice. Mech. Ageing Dev. 114, 123–132.
  • Langstrom N. S., Anderson J. P., Lindroos H. G., Winblad B. and Wallace W. C. (1989) Alzheimer's disease-associated reduction of polysomal mRNA translation. Brain Res. Mol. Brain Res. 5, 259–269.
  • Luo H., Duguid W., Chen H., Maheu M. and Wu J. (1994) The effect of rapamycin on T cell development in mice. Eur. J. Immunol. 24, 692–701.
    Direct Link:
  • Mattson M. P. and Chan S. L. (2003) Neuronal and glial calcium signaling in Alzheimer's disease. Cell. Calcium 34, 385–397.
  • Mecocci P., Polidori M. C., Cherubini A. et al. (2002) Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer's disease. Arch. Neurol. 59, 794–798.
  • Mengesdorf T., Proud C. G., Mies G. and Paschen W. (2002) Mechanisms underlying suppression of protein synthesis induced by transient focal cerebral ischemia in mouse brain. Exp. Neurol. 177, 538–546.
  • Nagy Z., Combrinck M., Budge M. and McShane R. (2002) Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer's disease. Neurosci. Lett. 317, 81–84.
  • Nguyen P. V. (2002) Protein synthesis during LTP: linking synaptic activity to translation. Trends Neurosci. 25, 4.
  • Palotas A., Kalman J., Palotas M., Juhasz A., Janka Z. and Penke B. (2002) Beta-amyloid-induced increase in the resting intracellular calcium concentration gives support to tell Alzheimer lymphocytes from control ones. Brain Res. Bull. 58, 203–205.
  • Peel A. L., Rao R. V., Cottrell B. A., Hayden M. R., Ellerby L. M. and Bredesen D. E. (2001) Double-stranded RNA-dependent protein kinase, PKR, binds preferentially to Huntington's disease (HD) transcripts and is activated in HD tissue. Hum. Mol. Genet. 10, 1531–1538.
  • Rattan S. I. (1996) Synthesis, modifications, and turnover of proteins during aging. Exp. Gerontol. 31, 33–47.
  • Raught B., Gingras A. C. and Sonenberg N. (2001) The target of rapamycin (TOR) proteins. Proc. Natl Acad. Sci. USA 98, 7037–7044.
  • Schmelzle T. and Hall M. N. (2000) mTOR, a central controller of cell growth. Cell 103, 253–262.
  • Stieler J. T., Lederer C., Bruckner M. K., Wolf H., Holzer M., Gertz H. J. and Arendt T. (2001) Impairment of mitogenic activation of peripheral blood lymphocytes in Alzheimer's disease. Neuroreport 12, 3969–3972.
  • Suen K. C., Yu M. S., So K. F., Chang R. C. and Hugon J. (2003) Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine/threonine protein kinase in beta-amyloid peptide neurotoxicity. J. Biol. Chem. 278, 49819–49827.
  • Tang S. J., Reis G., Kang H., Gingras A. C., Sonenberg N. and Schuman E. M. (2002) A rapamycin-sensitive pathway contributes to long-term synaptic plasticity in the hippocampus. Proc. Natl Acad. Sci. USA 99, 467–472.
  • Williams B. R. (1999) PKR; a sentinel kinase for cellular stress. Oncogene 18, 6112–6120.
  • Wirths O., Multhaup G., Czech C., Blanchard V., Tremp G., Pradier L., Beyreuther K. and Bayer T. A. (2001) Reelin in plaques of beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 316, 145–148.
  • Xu Z. and Williams B. R. (2000) The B56alpha regulatory subunit of protein phosphatase 2A is a target for regulation by double-stranded RNA-dependent protein kinase PKR. Mol. Cell Biol. 20, 5285–5299.
View Full Article (HTML) Get PDF (375K)